C
BSX icon

Cerebellum’s Boston Scientific BSX Stock Holding History

Cerebellum’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,100
Closed -$126K – 411
2020
Q2 		$126K Buy
+5,100
New +$184K 0.09% 228
2019
Q4 		$573K Buy
+12,676
New +$530K 0.3% 26
2019
Q2 		– Sell
-8,834
Closed -$339K – 436
2019
Q1 		$339K Buy
8,834
+1,024
+13% +$39.1K 0.29% 69
2018
Q4 		$276K Buy
+7,810
New +$283K 0.19% 4
2018
Q2 		– Sell
-4,666
Closed -$127K – 422
2018
Q1 		$127K Sell
4,666
-434
-9% -$11.8K 0.16% 332
2017
Q4 		$126K Buy
+5,100
New +$141K 0.09% 228

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cerebellum's BSX Position: Q3 2020 in Review

Cerebellum sold out of Boston Scientific (BSX) in Q3 2020, closing a stake of 5,100 shares — an estimated $126K sold.

Cerebellum first reported a position in BSX in Q4 2017 and held it in 6 quarters. The position peaked at $573K in Q4 2019. 843 funds tracked by Wall St. Rank hold BSX as of Q3 2020.

  • Cerebellum reported no remaining Boston Scientific position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 5,100 Boston Scientific shares in Q3 2020, an estimated $126K.
  • Cerebellum first reported a position in Boston Scientific in Q4 2017 and held it in 6 quarters.
  • Cerebellum's Boston Scientific position peaked at $573K in Q4 2019.
  • 843 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.